See every side of every news story
Published loading...Updated

EZZ Life Science posts strong quarterly results despite seasonal downturn

Summary by Inside FMCG
Genomic life science company, EZZ Life Science Holdings, reported strong results with an increased cash flow despite a dip in customer receipts and the launch of new products.  EZZ attributed its decreased customer receipts of $14.6 million in January, to a slow Chinese New Year period coupled with reduced digital advertising as compared to the same period last year. The company’s strong operating performance for the quarter resulted in $1.5 mil…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Inside FMCG broke the news in on Thursday, April 24, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.